Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2012 1
2015 1
2016 2
2017 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
Etiology and pathogenesis of Moyamoya Disease: An update on disease prevalence.
Huang S, Guo ZN, Shi M, Yang Y, Rao M. Huang S, et al. Int J Stroke. 2017 Apr;12(3):246-253. doi: 10.1177/1747493017694393. Epub 2017 Jan 1. Int J Stroke. 2017. PMID: 28381201 Review.
The occurrence of Moyamoya disease is related to immune, genetic, and other factors. Though the research of Moyamoya disease has made great strides in the past 60 years, the etiology and pathogenesis are largely unknown. ...
The occurrence of Moyamoya disease is related to immune, genetic, and other factors. Though the research of Moyamoya
Moyamoya Disease: A Review of Clinical Research.
Hishikawa T, Sugiu K, Date I. Hishikawa T, et al. Acta Med Okayama. 2016 Aug;70(4):229-36. doi: 10.18926/AMO/54497. Acta Med Okayama. 2016. PMID: 27549666 Free article. Review.
About 5 decades have passed since the concept of moyamoya disease (MMD) was established in Japan. In that time, many clinical MMD studies have been performed from several different points of view, such as epidemiology, pathophysiology, surgical procedures, an …
About 5 decades have passed since the concept of moyamoya disease (MMD) was established in Japan. In that time, many clinical …
A new horizon of moyamoya disease and associated health risks explored through RNF213.
Koizumi A, Kobayashi H, Hitomi T, Harada KH, Habu T, Youssefian S. Koizumi A, et al. Environ Health Prev Med. 2016 Mar;21(2):55-70. doi: 10.1007/s12199-015-0498-7. Epub 2015 Dec 10. Environ Health Prev Med. 2016. PMID: 26662949 Free PMC article. Review.
The cerebrovascular disorder moyamoya disease (MMD) was first described in 1957 in Japan, and is typically considered to be an Asian-specific disease. ...We also emphasize the importance of a more updated definition for MMD, of qualified cohort studies …
The cerebrovascular disorder moyamoya disease (MMD) was first described in 1957 in Japan, and is typically considered to be an …
Moyamoya disease: current concepts and future perspectives.
Kuroda S, Houkin K. Kuroda S, et al. Lancet Neurol. 2008 Nov;7(11):1056-66. doi: 10.1016/S1474-4422(08)70240-0. Lancet Neurol. 2008. PMID: 18940695 Review.
The incidence of moyamoya disease is high in east Asia, and familial forms account for about 15% of patients with this disease. ...Recent updates and future perspectives for moyamoya disease will also be discussed....
The incidence of moyamoya disease is high in east Asia, and familial forms account for about 15% of patients with this dise
Vascular risk profile and changes of arterial hypertension after surgical revascularization in adult Moyamoya patients.
Haas P, Wiggenhauser LM, Tellermann J, Hurth H, Feucht D, Tatagiba M, Khan N, Roder C. Haas P, et al. Sci Rep. 2024 May 29;14(1):12364. doi: 10.1038/s41598-024-61966-8. Sci Rep. 2024. PMID: 38811635 Free PMC article.
Moyamoya disease (MMD) is a rare stenoocclusive cerebral vasculopathy often treated by neurosurgical revascularization using extracranial-intracranial bypasses to prevent ischemic or hemorrhagic events. ...We therefore analyzed 133 adult MMD patients and compared th
Moyamoya disease (MMD) is a rare stenoocclusive cerebral vasculopathy often treated by neurosurgical revascularization using e
[Operative neurosurgery: personal view and historical backgrounds (9) Moyamoya angiopathy (MMA): past history and status presens].
Yonekawa Y. Yonekawa Y. No Shinkei Geka. 2012 Jan;40(1):67-87. No Shinkei Geka. 2012. PMID: 22223526 Japanese.
Who was the person who discovered this disease. 2. How has the Research Committee of the Ministry of Health and Welfare, Japan (RCMHWJ) contributed to clarify the epidemiology, etiology, pathophysiology and treatments. 3. ...Kudo who described "spontaneous oc …
Who was the person who discovered this disease. 2. How has the Research Committee of the Ministry of Health and Welfare, Japan (RCMHW …